LifeStance Health Group Inc. Common Stock vs MobilEye Global Inc — how do they compare? LifeStance Health Group Inc. Common Stock trades at $12.43 (market cap $4.58B), while MobilEye Global Inc trades at $7.16 (market cap $6.00B). The key difference: MobilEye Global Inc is the larger of the two by market cap, and LifeStance Health Group Inc. Common Stock is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold LifeStance Health Group Inc. Common Stock for 1 Days and MobilEye Global Inc for 15 Days on average.
| LFST | MBLY | |
|---|---|---|
Market Cap | $4.58B | $6.00B |
Volume | 2,356,698 | 7,007,849 |
Sector | Health | Consumer Cyclical |
52-Week High | $13.38 | $15.42 |
52-Week Low | $4.81 | $6.56 |
Typical Hold Time | 1 Days | 15 Days |
Enterprise Value | $4.82B | $4.56B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mobileye Global (MBLY) trades at $7.11, down 0.56% on the day, with a bearish technical outlook but mixed fundamental signals. The stock shows negative profitability with a net income margin of -201.49% for 2026, yet revenue grew to $2.0 billion. Recent earnings beats in Q1 and Q2 2026 contrast with a Q4 2025 miss, while analyst consensus is a 'Buy' with a $10.83 price target. News highlights ADAS momentum and a robotaxi strategy expansion, but the stock faces significant cash flow volatility.
The outlook for MBLY is cautious; while analyst optimism and revenue growth provide upside potential, persistent losses and bearish technicals pose risks. Investment opportunity hinges on execution of autonomous driving programs, but shareholders face volatility from negative earnings and high valuation multiples like EV/EBITDA of 32.34.
Trailing returns across standard periods
LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.
Read more on LFST →Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →